期刊
SCANDINAVIAN JOURNAL OF SURGERY
卷 100, 期 1, 页码 22-29出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/145749691110000105
关键词
HCC; hepatocellular carcinoma; radiofrequency ablation; percutaneous ablation procedures; percutaneous ethanol injection; intra-arterial therapy; transcatheter chemoembolization; liver resection; liver transplantation
类别
Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death worldwide. As over 90% of HCCs arise in cirrhotic livers preventive methods and surveillance policies have been adopted in most countries with high prevalence of hepatitis B or C infected people. Poor prognosis of HCC has shown some improvement during the last years. Targeted therapy with radiofrequency ablation (RFA), hepatic resection (HR), liver transplantation (LT), and transcatheter arterial chemoembolisation (TACE) seems to have an influence on this development. The heterogeneity of cirrhotic patients with HCC is still a big challenge. A patient with a small tumour in a cirrhotic liver may have a worse prognosis than a patient with a large tumor in a relatively preserved liver after curative HR. The choice of the treatment modality depends on the size and the number of tumours, the stage and the cause of cirrhosis and finally on the availability of various modalities in each centre.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据